MUNSELL WILLIAM A

SEC source: 0001209191-12-032847 · doc4.xml · nonDerivative · entry 1

MUNSELL WILLIAM A · CIK 0001308194 · EVP, UnitedHealth Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 268,167.37

SEC source: 0001209191-12-019219 · doc4.xml · nonDerivative · entry 1

MUNSELL WILLIAM A · CIK 0001308194 · EVP, UnitedHealth Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 275,464.37

F1 · shares: Represents payment of dividend equivalents on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if the related award does not vest.

SEC source: 0001209191-12-013615 · doc4.xml · nonDerivative · entry 1

MUNSELL WILLIAM A · CIK 0001308194 · EVP, UnitedHealth Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 275,248.546

SEC source: 0001209191-12-009051 · doc4.xml · nonDerivative · entry 2

MUNSELL WILLIAM A · CIK 0001308194 · EVP, UnitedHealth Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 295,248.546

SEC source: 0001209191-12-009051 · doc4.xml · nonDerivative · entry 1

MUNSELL WILLIAM A · CIK 0001308194 · EVP, UnitedHealth Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 298,374.546

SEC source: 0001209191-12-008712 · doc4.xml · nonDerivative · entry 3

MUNSELL WILLIAM A · CIK 0001308194 · EVP, UnitedHealth Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 304,315.546

F3 · shares: Represents the withholding of shares to satisfy tax obligations upon the settlement of Performance Share Awards for the performance period 2009-2011.

F4 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 7, 2012, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 38,440.

SEC source: 0001209191-12-008712 · doc4.xml · nonDerivative · entry 2

MUNSELL WILLIAM A · CIK 0001308194 · EVP, UnitedHealth Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 370,008.546

F2 · shares: Represents the settlement of Performance Share Awards for the performance period 2009-2011.

SEC source: 0001209191-12-008712 · doc4.xml · nonDerivative · entry 1

MUNSELL WILLIAM A · CIK 0001308194 · EVP, UnitedHealth Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 216,162.546

F1 · shares: The restricted stock units will vest at a rate of 33% on December 28, 2012; February 7, 2014; and February 7, 2015.

SEC source: 0001209191-12-008169 · doc4.xml · nonDerivative · entry 1

MUNSELL WILLIAM A · CIK 0001308194 · EVP, UnitedHealth Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 177,722.546

F1 · balance_after: Includes shares received through UnitedHealth Group Incorporated's Employee Stock Purchase Plan.

SEC source: 0001209191-11-062883 · doc4.xml · nonDerivative · entry 2

MUNSELL WILLIAM A · CIK 0001308194 · EVP, UnitedHealth Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 180,699.773

F3 · shares: Represents the cancellation of shares for the payment of a FICA tax liability.

F2 · balance_after: Includes shares received through UnitedHealth Group Incorporated's Employee Stock Purchase Plan.

SEC source: 0001209191-11-062883 · doc4.xml · nonDerivative · entry 1

MUNSELL WILLIAM A · CIK 0001308194 · EVP, UnitedHealth Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 182,036.773

F1 · shares: Represents payment of dividend equivalents on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if the related award does not vest.

F2 · balance_after: Includes shares received through UnitedHealth Group Incorporated's Employee Stock Purchase Plan.

SEC source: 0001209191-11-052744 · doc4.xml · derivative · entry 6

MUNSELL WILLIAM A · CIK 0001308194 · EVP, UnitedHealth Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 120,000 shares

Expires 2012-01-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock options vested at a rate of 25% annually on January 7 from the years 2003 through 2006.

SEC source: 0001209191-11-052744 · doc4.xml · derivative · entry 5

MUNSELL WILLIAM A · CIK 0001308194 · EVP, UnitedHealth Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 50,000 shares

Expires 2012-08-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The stock options vest at a rate of 25% annually on August 5 from the years 2003 through 2006.

SEC source: 0001209191-11-052744 · doc4.xml · nonDerivative · entry 3

MUNSELL WILLIAM A · CIK 0001308194 · EVP, UnitedHealth Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 181,209.815

SEC source: 0001209191-11-052744 · doc4.xml · nonDerivative · entry 2

MUNSELL WILLIAM A · CIK 0001308194 · EVP, UnitedHealth Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 351,209.815

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-11-052744 · doc4.xml · nonDerivative · entry 1

MUNSELL WILLIAM A · CIK 0001308194 · EVP, UnitedHealth Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 231,209.815

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-11-048794 · doc4.xml · nonDerivative · entry 2

MUNSELL WILLIAM A · CIK 0001308194 · EVP, UnitedHealth Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 181,209.815

F1 · shares: Represents payment of dividend equivalents on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if the related award does not vest.

SEC source: 0001209191-11-048794 · doc4.xml · nonDerivative · entry 1

MUNSELL WILLIAM A · CIK 0001308194 · EVP, UnitedHealth Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 181,027.702

F1 · shares: Represents payment of dividend equivalents on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if the related award does not vest.

SEC source: 0001209191-11-033552 · doc4.xml · nonDerivative · entry 1

MUNSELL WILLIAM A · CIK 0001308194 · EVP, UnitedHealth Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 180,860.79

SEC source: 0001209191-11-019263 · doc4.xml · nonDerivative · entry 1

MUNSELL WILLIAM A · CIK 0001308194 · EVP, UnitedHealth Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 188,157.79

F1 · shares: Represents payment of dividend equivalents on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if the related award does not vest.

SEC source: 0001209191-11-008863 · doc4.xml · nonDerivative · entry 2

MUNSELL WILLIAM A · CIK 0001308194 · EVP, UnitedHealth Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 188,003

F1 · shares: The restricted stock units will vest at a rate of 33% on February 9, 2012; December 28, 2012; and February 9, 2014.

F2 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 9, 2011, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 53,483.

SEC source: 0001209191-11-008863 · doc4.xml · nonDerivative · entry 1

MUNSELL WILLIAM A · CIK 0001308194 · EVP, UnitedHealth Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 134,520

SEC source: 0001209191-11-007318 · doc4.xml · nonDerivative · entry 1

MUNSELL WILLIAM A · CIK 0001308194 · EVP & Pres Enterprise Svcs Grp

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 136,654

SEC source: 0001209191-10-060706 · doc4.xml · nonDerivative · entry 1

MUNSELL WILLIAM A · CIK 0001308194 · EVP & Pres Enterprise Svcs Grp

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 139,659

F1 · shares: Represents the cancellation of shares for the payment of a FICA tax liability.

F2 · balance_after: Includes shares and dividend shares received through UnitedHealth Group Incorporated's Employee Stock Purchase Plan.

SEC source: 0000731766-10-000072 · edgardoc.xml · nonDerivative · entry 1

MUNSELL WILLIAM A · CIK 0001308194 · EVP & Pres Enterprise Svcs Grp

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 139,506

F1 · balance_after: Includes dividend shares received through UnitedHealth Group Incorporated's Employee Stock Purchase Plan.

SEC source: 0000731766-10-000027 · edgardoc.xml · derivative · entry 3

MUNSELL WILLIAM A · CIK 0001308194 · EVP & Pres Enterprise Svcs Grp

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,024

Underlying: Common Stock · 76,024 shares

Expires 2020-02-09

F3 · derivative.exercise_date: The stock appreciation rights will vest at a rate of 25% annually on February 9 from the years 2011 through 2014.

SEC source: 0000731766-10-000027 · edgardoc.xml · nonDerivative · entry 1

MUNSELL WILLIAM A · CIK 0001308194 · EVP & Pres Enterprise Svcs Grp

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 146,783

F1 · shares: The restricted stock units will vest at a rate of 25% annually on February 9 from the years 2011 through 2014.

F2 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 9, 2010, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 60,607. Amount does include shares acquired under UnitedHealth Group's Employee Stock Purchase Plan.

SEC source: 0000731766-10-000014 · edgardoc.xml · nonDerivative · entry 1

MUNSELL WILLIAM A · CIK 0001308194 · EVP & Pres Enterprise Svcs Grp

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 116,479

F1 · balance_after: Includes shares acquired under UnitedHealth Group's Employee Stock Purchase Plan.

SEC source: 0000731766-09-000102 · edgardoc.xml · nonDerivative · entry 1

MUNSELL WILLIAM A · CIK 0001308194 · EVP & Pres Enterprise Svcs Grp

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,186

F1 · shares: Represents the cancellation of shares for the payment of a FICA tax liability.

F2 · balance_after: Includes shares acquired under UnitedHealth Group's Employee Stock Purchase Plan.

SEC source: 0000731766-09-000061 · edgardoc.xml · nonDerivative · entry 1

MUNSELL WILLIAM A · CIK 0001308194 · EVP & Pres Enterprise Svcs Grp

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,229

F1 · balance_after: Includes dividend shares received through UnitedHealth Group's Employee Stock Purchase Plan.

SEC source: 0000731766-09-000035 · edgardoc.xml · derivative · entry 3

MUNSELL WILLIAM A · CIK 0001308194 · EVP & Pres Enterprise Svcs Grp

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,122

Underlying: Common Stock · 113,122 shares

Expires 2019-02-23

F3 · derivative.exercise_date: The stock appreciation rights vest at a rate of 25% annually on February 3 from the years 2010 through 2013.

SEC source: 0000731766-09-000035 · edgardoc.xml · nonDerivative · entry 1

MUNSELL WILLIAM A · CIK 0001308194 · EVP & Pres Enterprise Svcs Grp

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,923

F1 · security: The restricted stock units will vest at a rate of 25% annually on February 3 from the years 2010 through 2013.

F2 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 23, 2009, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of average EPS growth percentanges and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 76,923. Amount does include shares acquired under UnitedHealth Group's Employee Stock Purchase Plan.

SEC source: 0000731766-08-000097 · edgardoc.xml · derivative · entry 3

MUNSELL WILLIAM A · CIK 0001308194 · EVP & Pres Enterprise Svcs Grp

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,851

Underlying: Common Stock · 84,851 shares

Expires 2018-06-05

F3 · derivative.exercise_date: The stock appreciation rights vest at a rate of 25% annually on June 5 from the years 2009 through 2012.

SEC source: 0000731766-08-000097 · edgardoc.xml · nonDerivative · entry 1

MUNSELL WILLIAM A · CIK 0001308194 · EVP & Pres Enterprise Svcs Grp

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,019

F1 · security: The restricted stock units will vest at a rate of 25% annually on June 5 from the years 2009 through 2012.

F2 · balance_after: Includes shares acquired under UnitedHealth Group's Employee Stock Purchase Plan.

SEC source: 0001181431-06-062879 · rrd135934.xml · derivative · entry 6

MUNSELL WILLIAM A · CIK 0001308194 · CEO, Specialized Care Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,000

Underlying: Common Stock · 120,000 shares

Expires 2012-08-05

F1 · derivative.exercise_price: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)

F2 · derivative.exercise_price: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information.For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · kind: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)

F2 · kind: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information.For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · price: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)

F2 · price: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information.For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · derivative.exercise_date: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)

F2 · derivative.exercise_date: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information.For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

SEC source: 0001181431-06-062879 · rrd135934.xml · derivative · entry 5

MUNSELL WILLIAM A · CIK 0001308194 · CEO, Specialized Care Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 120,000 shares

Expires 2012-08-05

F1 · kind: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)

F2 · kind: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information.For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · price: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)

F2 · price: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information.For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · derivative.exercise_date: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)

F2 · derivative.exercise_date: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information.For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

SEC source: 0001181431-06-062879 · rrd135934.xml · derivative · entry 4

MUNSELL WILLIAM A · CIK 0001308194 · CEO, Specialized Care Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 160,000

Underlying: Common Stock · 160,000 shares

Expires 2012-01-07

F1 · derivative.exercise_price: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)

F2 · derivative.exercise_price: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information.For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · kind: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)

F2 · kind: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information.For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · price: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)

F2 · price: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information.For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · derivative.exercise_date: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)

F2 · derivative.exercise_date: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information.For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

SEC source: 0001181431-06-062879 · rrd135934.xml · derivative · entry 3

MUNSELL WILLIAM A · CIK 0001308194 · CEO, Specialized Care Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 160,000 shares

Expires 2012-01-07

F1 · kind: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)

F2 · kind: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information.For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · price: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)

F2 · price: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information.For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · derivative.exercise_date: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)

F2 · derivative.exercise_date: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information.For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

SEC source: 0001181431-06-062879 · rrd135934.xml · derivative · entry 2

MUNSELL WILLIAM A · CIK 0001308194 · CEO, Specialized Care Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2011-01-17

F1 · derivative.exercise_price: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)

F2 · derivative.exercise_price: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information.For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · kind: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)

F2 · kind: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information.For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · price: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)

F2 · price: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information.For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · derivative.exercise_date: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)

F2 · derivative.exercise_date: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information.For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

SEC source: 0001181431-06-062879 · rrd135934.xml · derivative · entry 1

MUNSELL WILLIAM A · CIK 0001308194 · CEO, Specialized Care Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 150,000 shares

Expires 2011-01-17

F1 · kind: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)

F2 · kind: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information.For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · price: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)

F2 · price: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information.For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

F1 · derivative.exercise_date: The reporting person has entered into an agreement, dated November 7, 2006 (the "Agreement"), with UnitedHealth Group Incorporated (the "Company") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a "Subject Option") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant. If any such closing price is less than the exercise price of the related option, no adjustment will be made. These accounting measurement dates are being determined by the Company (the date of the determination, the "Determination Date"). In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)

F2 · derivative.exercise_date: The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options. Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options. See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information.For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.

SEC source: 0000731766-06-000054 · edgardoc.xml · derivative · entry 1

MUNSELL WILLIAM A · CIK 0001308194 · CEO, Specialized Care Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2016-05-02

SEC source: 0000731766-05-000131 · edgardoc.xml · derivative · entry 1

MUNSELL WILLIAM A · CIK 0001308194 · CEO, Specialized Care Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2015-10-31

SEC source: 0000731766-05-000072 · edgardoc.xml · derivative · entry 1

MUNSELL WILLIAM A · CIK 0001308194 · CEO, Specialized Care Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2015-05-02

F1 · derivative.exercise_date: The option is exercisable in four equal annual installments beginning May 2, 2006.

SEC source: 0000731766-05-000033 · edgardoc.xml · derivative · entry 20

MUNSELL WILLIAM A · CIK 0001308194 · CEO, Specialized Care Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 15,000 shares

Expires 2011-01-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option is exercisable in four equal annual installments beginning 1/17/02.

SEC source: 0000731766-05-000033 · edgardoc.xml · derivative · entry 19

MUNSELL WILLIAM A · CIK 0001308194 · CEO, Specialized Care Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 60,000 shares

Expires 2010-07-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option is exercisable in four equal annual installments beginning 7/26/01.

SEC source: 0000731766-05-000033 · edgardoc.xml · derivative · entry 18

MUNSELL WILLIAM A · CIK 0001308194 · CEO, Specialized Care Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,504 shares

Expires 2008-02-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option is exercisable as follows: 25% on 2/6/99; 18.75% on each of August 1, 2001, 2002 and 2003; and 18.75% on February 6, 2004.

SEC source: 0000731766-05-000033 · edgardoc.xml · derivative · entry 17

MUNSELL WILLIAM A · CIK 0001308194 · CEO, Specialized Care Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 40 shares

Expires 2009-10-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option is exercisable in four equal annual installments beginning December 1, 2000.

SEC source: 0000731766-05-000033 · edgardoc.xml · nonDerivative · entry 16

MUNSELL WILLIAM A · CIK 0001308194 · CEO, Specialized Care Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,600

SEC source: 0000731766-05-000033 · edgardoc.xml · nonDerivative · entry 15

MUNSELL WILLIAM A · CIK 0001308194 · CEO, Specialized Care Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,700

SEC source: 0000731766-05-000033 · edgardoc.xml · nonDerivative · entry 14

MUNSELL WILLIAM A · CIK 0001308194 · CEO, Specialized Care Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,800